Here, we demonstrate that integrin αV (ITGAV) is a prognostic biomarker of tumor relapse, detecting cSCC epithelial plastic cancer cells with a hybrid E/M phenotype and an increased ability to progress to the aggressive mesenchymal phenotype. This evidence concerns the gene ITGAV and cancer.